Replies to post #257764 on NorthWest Biotherapeutics Inc (NWBO)

[alexander77]

I think DFFN will be the number one stock for 2020. 86% survival at two years for inoperable GBM versus 13% in SOC in an open label study and 4x better overall survival in phase 2 vs historical data.
That is really extraordinary.